Cathy being persistent




time and dose control:


material ID time dose ROA notes
037C013E 18:04 unknown non invasive liver-bypassing route initial dose. not much euphoria, mild familiar stimulation.
037C013E 19:23 unknown non invasive liver-bypassing route maintenance at the same level of stimulation, no additional euphoria.
037C013E 20:10 unknown non invasive liver-bypassing route compulsion starting to act in the subject place. additional stimulation noticeable.
037C013E 21:42 unknown non invasive liver-bypassing route not the setting i'd wish
037C013E 00:30 unknown non invasive liver-bypassing route working on chemistry topics, and general pharmaceuticals related matters. Even more global simple physics and chemistry. Thermodynamics, kinetics...
30DB0626 17:00 20 mg oral initial dose.
30DB0626 17:02 20 mg nasal the combined oral and nasal doses yielded rather satisfying results
0B4502D3 03:25 unknown nasal contemplation of failure.